A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer

CONCLUSIONS: The RGPT for prostate cancer with 1.5-mm markers and 3- or 4- fields was as safe as conventional proton therapy in early AE, and its efficacy was comparable with previous studies.PMID:38560429 | PMC:PMC10981019 | DOI:10.1016/j.adro.2024.101464

Source: Adv Data - April 1, 2024 Category: Epidemiology Authors: Kentaro Nishioka Takayuki Hashimoto Takashi Mori Yusuke Uchinami Rumiko Kinoshita Norio Katoh Hiroshi Taguchi Koichi Yasuda Yoichi M Ito Seishin Takao Masaya Tamura Taeko Matsuura Shinichi Shimizu Hiroki Shirato Hidefumi Aoyama Source Type: research